[On the therapeutic effectiveness of prodigiozan in chronic colitis].
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002764:Cholecystitis / Q000150:complications; D002908:Chronic Disease; D003092:Colitis / Q000188:drug therapy*; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D005260:Female; D005756:Gastritis / Q000150:complications; D006505:Hepatitis / Q000150:complications; D006801:Humans; D007417:Intestinal Polyps / Q000150:complications; D008297:Male; D008875:Middle Aged; D010437:Peptic Ulcer / Q000150:complications; D011135:Polysaccharides, Bacterial / Q000627:therapeutic use*; D012706:Serratia marcescens
D000970:Antineoplastic Agents; D011135:Polysaccharides, Bacterial
O lechebnoĭ éffektivnosti prodigiozana pri khronicheskikh kolitakh.